Xilio Therapeutics, Inc. (XLO)
NASDAQ·Healthcare·Biotechnology
$8.14
+1.62%
Mkt Cap $28.36M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$98.00
Range $98.00 – $98.00
Implied Upside
+1103.9%
Consensus $98.00 vs current $8.14
NASDAQ·Healthcare·Biotechnology
$8.14
+1.62%
Mkt Cap $28.36M
No recent rating data.
Price Target (1 analysts)
$98.00
Range $98.00 – $98.00
+1103.9%
Consensus $98.00 vs current $8.14